MRFRの分析によると、呼吸器系ウイルスワクチンの市場規模は2022年に21.95 (10億ドル) と推定されました。この市場は2023年の23.19 (10億ドル) から2032年までに38.1 (10億ドル) に成長し、予測期間 (2024-2032) のCAGRは約5.67%になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. RESPIRATORY VIRUS VACCINES MARKET, BY VACCINE TYPE (USD BILLION)
6.1. Influenza Vaccines
6.2. Pneumococcal Vaccines
6.3. Respiratory Syncytial Virus (RSV) Vaccines
6.4. Parainfluenza Virus Vaccines
6.5. Others
7. RESPIRATORY VIRUS VACCINES MARKET, BY ADMINISTRATION ROUTE (USD BILLION)
7.1. Injectable
7.2. Nasal
7.3. Others
8. RESPIRATORY VIRUS VACCINES MARKET, BY TARGET POPULATION (USD BILLION)
8.1. Children
8.2. Adults
8.3. Elderly
8.4. Immunocompromised Individuals
8.5. Others
9. RESPIRATORY VIRUS VACCINES MARKET, BY TECHNOLOGY PLATFORM (USD BILLION)
9.1. Live Attenuated Vaccines
9.2. Inactivated Vaccines
9.3. Subunit Vaccines
9.4. DNA Vaccines
9.5. Others
10. RESPIRATORY VIRUS VACCINES MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
10.1. Hospitals
10.2. Clinics
10.3. Pharmacies
10.4. Government Agencies
10.5. Online Retailers
11. RESPIRATORY VIRUS VACCINES MARKET, BY REGIONAL (USD BILLION)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. UK
11.2.3. France
11.2.4. Russia
11.2.5. Italy
11.2.6. Spain
11.2.7. Rest of Europe
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Malaysia
11.3.6. Thailand
11.3.7. Indonesia
11.3.8. Rest of APAC
11.4. South America
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of South America
11.5. MEA
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of MEA
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market share Analysis
12.4. Major Growth Strategy in the Respiratory Virus Vaccines Market
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Respiratory Virus Vaccines Market
12.7. Key developments and growth strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales and Operating Income
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. Pfizer
13.1.1. Financial Overview
13.1.2. Products Offered
13.1.3. Key Developments
13.1.4. SWOT Analysis
13.1.5. Key Strategies
13.2. CureVac
13.2.1. Financial Overview
13.2.2. Products Offered
13.2.3. Key Developments
13.2.4. SWOT Analysis
13.2.5. Key Strategies
13.3. Moderna Therapeutics
13.3.1. Financial Overview
13.3.2. Products Offered
13.3.3. Key Developments
13.3.4. SWOT Analysis
13.3.5. Key Strategies
13.4. Novavax
13.4.1. Financial Overview
13.4.2. Products Offered
13.4.3. Key Developments
13.4.4. SWOT Analysis
13.4.5. Key Strategies
13.5. GlaxoSmithKline (GSK)
13.5.1. Financial Overview
13.5.2. Products Offered
13.5.3. Key Developments
13.5.4. SWOT Analysis
13.5.5. Key Strategies
13.6. Inovio Pharmaceuticals
13.6.1. Financial Overview
13.6.2. Products Offered
13.6.3. Key Developments
13.6.4. SWOT Analysis
13.6.5. Key Strategies
13.7. Altimmune
13.7.1. Financial Overview
13.7.2. Products Offered
13.7.3. Key Developments
13.7.4. SWOT Analysis
13.7.5. Key Strategies
13.8. AstraZeneca
13.8.1. Financial Overview
13.8.2. Products Offered
13.8.3. Key Developments
13.8.4. SWOT Analysis
13.8.5. Key Strategies
13.9. Merck
13.9.1. Financial Overview
13.9.2. Products Offered
13.9.3. Key Developments
13.9.4. SWOT Analysis
13.9.5. Key Strategies
13.10. Seqirus (CSL)
13.10.1. Financial Overview
13.10.2. Products Offered
13.10.3. Key Developments
13.10.4. SWOT Analysis
13.10.5. Key Strategies
13.11. Dynavax Technologies Corporation
13.11.1. Financial Overview
13.11.2. Products Offered
13.11.3. Key Developments
13.11.4. SWOT Analysis
13.11.5. Key Strategies
13.12. Sanofi Pasteur
13.12.1. Financial Overview
13.12.2. Products Offered
13.12.3. Key Developments
13.12.4. SWOT Analysis
13.12.5. Key Strategies
13.13. Johnson Johnson
13.13.1. Financial Overview
13.13.2. Products Offered
13.13.3. Key Developments
13.13.4. SWOT Analysis
13.13.5. Key Strategies
13.14. MedImmune (AstraZeneca)
13.14.1. Financial Overview
13.14.2. Products Offered
13.14.3. Key Developments
13.14.4. SWOT Analysis
13.14.5. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 7. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 8. US RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 9. US RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 10. US RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 11. US RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 12. US RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 13. US RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 17. CANADA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 18. CANADA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 19. CANADA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 22. EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 23. EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 24. EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 25. EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 27. GERMANY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 28. GERMANY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 29. GERMANY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 30. GERMANY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 31. GERMANY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. UK RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. UK RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 34. UK RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 35. UK RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 36. UK RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 37. UK RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. FRANCE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. FRANCE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 40. FRANCE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 41. FRANCE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 42. FRANCE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 43. FRANCE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 44. RUSSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 45. RUSSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 46. RUSSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 47. RUSSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 48. RUSSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 49. RUSSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. ITALY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. ITALY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 52. ITALY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 53. ITALY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 54. ITALY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 55. ITALY RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 56. SPAIN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 57. SPAIN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 58. SPAIN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 59. SPAIN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 60. SPAIN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 61. SPAIN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 64. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 65. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 66. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 67. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 68. APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 69. APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 70. APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 71. APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 72. APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 73. APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. CHINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. CHINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 76. CHINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 77. CHINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 78. CHINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 79. CHINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 80. INDIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 81. INDIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 82. INDIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 83. INDIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 84. INDIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 85. INDIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. JAPAN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 87. JAPAN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 88. JAPAN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 89. JAPAN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 90. JAPAN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 91. JAPAN RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 94. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 95. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 96. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 97. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 100. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 101. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 102. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 103. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 104. THAILAND RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 105. THAILAND RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 106. THAILAND RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 107. THAILAND RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 108. THAILAND RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 109. THAILAND RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. INDONESIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. INDONESIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 112. INDONESIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 113. INDONESIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 114. INDONESIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 115. INDONESIA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 118. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 119. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 120. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 121. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 124. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 125. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 126. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 127. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 128. BRAZIL RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 129. BRAZIL RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 130. BRAZIL RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 131. BRAZIL RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 132. BRAZIL RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 133. BRAZIL RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 134. MEXICO RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 135. MEXICO RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 136. MEXICO RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 137. MEXICO RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 138. MEXICO RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 139. MEXICO RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 140. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 141. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 142. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 143. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 144. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 145. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 147. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 148. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 149. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 150. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 151. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 152. MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 153. MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 154. MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 155. MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 156. MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 157. MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 158. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 159. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 160. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 161. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 162. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 163. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 164. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 165. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 166. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 167. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 168. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 169. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 170. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2032 (USD BILLIONS)
TABLE 171. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 172. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TARGET POPULATION, 2019-2032 (USD BILLIONS)
TABLE 173. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY PLATFORM, 2019-2032 (USD BILLIONS)
TABLE 174. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 175. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 176. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 177. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS
FIGURE 3. US RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 4. US RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 5. US RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 6. US RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 7. US RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 8. US RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 9. CANADA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 10. CANADA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 11. CANADA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 12. CANADA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 13. CANADA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 14. CANADA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 15. EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS
FIGURE 16. GERMANY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 17. GERMANY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 18. GERMANY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 19. GERMANY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 20. GERMANY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 21. GERMANY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 22. UK RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 23. UK RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 24. UK RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 25. UK RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 26. UK RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 27. UK RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 28. FRANCE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 29. FRANCE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 30. FRANCE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 31. FRANCE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 32. FRANCE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 33. FRANCE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 34. RUSSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 35. RUSSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 36. RUSSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 37. RUSSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 38. RUSSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 39. RUSSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 40. ITALY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 41. ITALY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 42. ITALY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 43. ITALY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 44. ITALY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 45. ITALY RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 46. SPAIN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 47. SPAIN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 48. SPAIN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 49. SPAIN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 50. SPAIN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 51. SPAIN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 52. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 53. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 54. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 55. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 56. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 57. REST OF EUROPE RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 58. APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS
FIGURE 59. CHINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 60. CHINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 61. CHINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 62. CHINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 63. CHINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 64. CHINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 66. INDIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 67. INDIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 68. INDIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 69. INDIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 70. INDIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 71. JAPAN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 72. JAPAN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 73. JAPAN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 74. JAPAN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 75. JAPAN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 76. JAPAN RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 77. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 78. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 79. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 80. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 81. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 82. SOUTH KOREA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 83. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 84. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 85. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 86. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 87. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 88. MALAYSIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 89. THAILAND RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 90. THAILAND RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 91. THAILAND RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 92. THAILAND RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 93. THAILAND RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 94. THAILAND RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 95. INDONESIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 96. INDONESIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 97. INDONESIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 98. INDONESIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 99. INDONESIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 100. INDONESIA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 101. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 102. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 103. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 104. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 105. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 106. REST OF APAC RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 107. SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS
FIGURE 108. BRAZIL RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 109. BRAZIL RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 110. BRAZIL RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 111. BRAZIL RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 112. BRAZIL RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 113. BRAZIL RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 114. MEXICO RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 115. MEXICO RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 116. MEXICO RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 117. MEXICO RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 118. MEXICO RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 119. MEXICO RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 120. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 121. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 122. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 123. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 124. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 125. ARGENTINA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 126. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 127. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 128. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 129. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 130. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 131. REST OF SOUTH AMERICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 132. MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS
FIGURE 133. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 134. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 135. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 136. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 137. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 138. GCC COUNTRIES RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 139. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 140. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 141. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 142. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 143. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 144. SOUTH AFRICA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 145. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 146. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 147. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TARGET POPULATION
FIGURE 148. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY TECHNOLOGY PLATFORM
FIGURE 149. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 150. REST OF MEA RESPIRATORY VIRUS VACCINES MARKET ANALYSIS BY REGIONAL
FIGURE 151. KEY BUYING CRITERIA OF RESPIRATORY VIRUS VACCINES MARKET
FIGURE 152. RESEARCH PROCESS OF MRFR
FIGURE 153. DRO ANALYSIS OF RESPIRATORY VIRUS VACCINES MARKET
FIGURE 154. DRIVERS IMPACT ANALYSIS: RESPIRATORY VIRUS VACCINES MARKET
FIGURE 155. RESTRAINTS IMPACT ANALYSIS: RESPIRATORY VIRUS VACCINES MARKET
FIGURE 156. SUPPLY / VALUE CHAIN: RESPIRATORY VIRUS VACCINES MARKET
FIGURE 157. RESPIRATORY VIRUS VACCINES MARKET, BY VACCINE TYPE, 2024 (% SHARE)
FIGURE 158. RESPIRATORY VIRUS VACCINES MARKET, BY VACCINE TYPE, 2019 TO 2032 (USD Billions)
FIGURE 159. RESPIRATORY VIRUS VACCINES MARKET, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
FIGURE 160. RESPIRATORY VIRUS VACCINES MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2032 (USD Billions)
FIGURE 161. RESPIRATORY VIRUS VACCINES MARKET, BY TARGET POPULATION, 2024 (% SHARE)
FIGURE 162. RESPIRATORY VIRUS VACCINES MARKET, BY TARGET POPULATION, 2019 TO 2032 (USD Billions)
FIGURE 163. RESPIRATORY VIRUS VACCINES MARKET, BY TECHNOLOGY PLATFORM, 2024 (% SHARE)
FIGURE 164. RESPIRATORY VIRUS VACCINES MARKET, BY TECHNOLOGY PLATFORM, 2019 TO 2032 (USD Billions)
FIGURE 165. RESPIRATORY VIRUS VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
FIGURE 166. RESPIRATORY VIRUS VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2032 (USD Billions)
FIGURE 167. RESPIRATORY VIRUS VACCINES MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 168. RESPIRATORY VIRUS VACCINES MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 169. BENCHMARKING OF MAJOR COMPETITORS
